s6y Ernexa Therapeutics Inc. EFFECT

Ernexa Therapeutics Inc. EFFECT, filed Nov 26, 2021: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 26, 2021 9:00 A.M.
Form: S-1
CIK: 0000748592
Company Name: Brooklyn ImmunoTherapeutics, Inc.
File Number: 333-261185